Codiak BioSciences (CDAK)

Codiak BioSciences (CDAK) Financial Statements


Codiak BioSciences Financial Overview

Codiak BioSciences's market cap is currently ―. The company's EPS TTM is $; its P/E ratio is ―; Codiak BioSciences is scheduled to report earnings on ―, and the estimated EPS forecast is $―. See an overview of income statement, balance sheet, and cash flow financials.
Sep 22Jun 22Mar 22Dec 21Sep 21
Income Statement-
Total Revenue$ 28.00K$ 13.14M$ 12.70M$ 7.70M$ 1.16M
Gross Profit-----
EBIT$ -18.52M$ -6.13M$ -7.43M$ 17.27M$ -21.01M
EBITDA$ -17.47M$ -5.39M$ -6.03M$ 18.74M$ -19.31M
Net Income Common Stockholders$ -19.28M$ -6.78M$ -8.03M$ 16.66M$ -21.70M
Balance Sheet-
Cash, Cash Equivalents and Short-Term Investments$ 51.76M$ 41.78M$ 56.49M$ 76.94M$ 98.58M
Total Assets$ 134.40M$ 132.71M$ 150.07M$ 171.67M$ 158.72M
Total Debt$ 61.28M$ 61.85M$ 62.42M$ 62.98M$ 62.45M
Net Debt$ 9.52M$ 20.06M$ 5.93M$ -13.96M$ -36.13M
Total Liabilities$ 95.47M$ 88.31M$ 101.69M$ 118.17M$ 124.72M
Stockholders Equity$ 38.93M$ 44.40M$ 48.38M$ 53.51M$ 34.01M
Cash Flow-
Free Cash Flow$ -10.12M$ -14.77M$ -21.03M$ -21.85M$ -15.85M
Operating Cash Flow$ -10.11M$ -14.60M$ -20.85M$ -21.52M$ -15.30M
Investing Cash Flow$ -9.00K$ -171.00K$ -182.00K$ -332.00K$ -548.00K
Financing Cash Flow$ 20.10M$ 59.00K$ 589.00K$ 208.00K$ 753.00K
Currency in USD

Codiak BioSciences Earnings and Revenue History

Codiak BioSciences Debt to Assets

Codiak BioSciences Cash Flow

Codiak BioSciences Forecast EPS vs Actual EPS

Currently, no data available
Please return soon. This page is being updated.
What's Included in PREMIUM?
Make informed decisions based on Top Analysts' activity
Know what industry insiders are buying
Get actionable alerts from top Wall Street Analysts
Find out before anyone else which stock is going to shoot up
Get powerful stock screeners & detailed portfolio analysis